ACRP-PI logo
Focused certification exam prep
Start practice

ACRP-PI Domain 2: Ethical and Safety Considerations (22%) - Complete Study Guide 2026

TL;DR
  • Domain 2 is worth 22% of your score - the single largest domain on the 125-question ACRP-PI exam.
  • ICH E6(R3) replaces E6(R2) as the governing GCP standard on July 15, 2026; study the updated version now.
  • Informed consent elements, SAE reporting timelines, and IRB communication are the highest-frequency topic clusters in this domain.
  • The exam tests PI-level judgment, not textbook recall - expect scenario-based questions where you must choose the most appropriate PI action.

Why Domain 2 Carries the Most Weight

Of the six domains tested on the ACRP-PI exam, Ethical and Safety Considerations weighs in at 22% - heavier than any other content area, including Clinical Trial Operations (21%) or Study and Site Management (17%). That weighting is not arbitrary. The credential exists to verify that a principal investigator can be trusted to protect participants while generating valid data. Ethics and safety are the core of that mandate.

On a 125-question exam with a scaled passing score of 600, Domain 2 likely accounts for roughly 27 scored questions. Getting those questions right is one of the most efficient ways to build the margin you need, because this is also the domain where candidates who rely on operations experience alone - without structured exam preparation - tend to lose ground. Many real-world PIs know their site's SOPs but haven't recently reviewed the foundational documents that underpin every ethical decision: the Belmont Report, the Declaration of Helsinki, and now ICH E6(R3).

Before diving into content, review how Domain 2 fits alongside every other content area in our ACRP-PI Exam Domains 2026: Complete Guide to All 6 Content Areas, which shows the full weighting breakdown and gives you a roadmap for balancing your prep time.

Core Ethical Frameworks You Must Know Cold

The ACRP-PI exam is an ICH-only exam - not country-specific. That means questions are anchored to internationally recognized ethical frameworks rather than any single national regulatory code. You need a fluent understanding of these documents, not just awareness that they exist.

Essential Ethical Documents for Domain 2

Each document below appears in the content outline and generates exam questions at the application level.

  • Nuremberg Code (1947): Established voluntary consent as the foundation of ethical research. The exam may test its historical significance in the context of what happens when protections are absent.
  • Declaration of Helsinki: World Medical Association document governing physician-researcher obligations. Key principles include therapeutic misconception, equipoise, and post-trial access. Know the difference between therapeutic and non-therapeutic research.
  • Belmont Report: Three principles - respect for persons, beneficence, and justice - that map directly to informed consent, risk-benefit assessment, and fair subject selection. Expect questions that ask you to identify which principle applies in a clinical scenario.
  • ICH E6(R3): The current GCP guideline replacing E6(R2) as of July 15, 2026. Introduces a risk-based approach and proportionality principle for oversight activities.
  • CIOMS Guidelines: Addresses global research ethics, particularly relevant to research in resource-limited settings and fair distribution of research burdens and benefits.

Exam questions in this area rarely ask you to recite a document. They present a scenario - a sponsor suggests skipping a consent step to accelerate enrollment, or a participant from a vulnerable group struggles to understand study risks - and ask what the PI should do. Your answer needs to be grounded in these frameworks even if they aren't explicitly named in the stem.

Informed consent is the single most tested sub-topic within Domain 2. PIs bear direct responsibility for ensuring consent is valid, ongoing, and properly documented. The exam tests this at a granular level.

The Required Elements

ICH E6 defines the required elements of informed consent, and you need to know all of them. These include: a statement that the study involves research; the purpose and duration; foreseeable risks and discomforts; anticipated benefits; alternative treatments; confidentiality protections; compensation for injury; contact information for questions; and the voluntary nature of participation with the right to withdraw without penalty.

Beyond the list, the exam asks about process. Was adequate time given? Was the participant in a coercive environment (e.g., a prisoner, a student of the investigator, an employee)? Was a legally authorized representative used appropriately? Was re-consent triggered by a protocol amendment that changed the risk profile?

High-Yield Consent Scenarios: The exam frequently tests situations where re-consent is required - new safety information emerges mid-study, a protocol amendment adds a new procedure, or a participant loses and later regains decision-making capacity. In each case, the PI's obligation is to ensure the participant's ongoing willingness to participate is affirmed with full, updated information before the next study procedure.

Waiver of Informed Consent

IRBs can approve a waiver or alteration of informed consent under specific, narrow conditions - the research poses no more than minimal risk, the waiver won't adversely affect participants' rights, and the research couldn't practicably be carried out otherwise. The PI must understand these conditions and recognize when a waiver request from a sponsor is inappropriate.

Consent in Special Populations

Pediatric research requires assent from the child (when developmentally appropriate) in addition to parental permission. Cognitively impaired participants require a legally authorized representative but should still be informed to the extent possible. Non-English speakers require translated consent forms and qualified interpreters. These aren't edge cases on the exam - they appear regularly because they represent real challenges PIs must navigate.

IRB and Ethics Committee Responsibilities

The PI's relationship with the IRB (called an Independent Ethics Committee or IEC in ICH terminology) is a core Domain 2 topic. The exam tests what requires IRB review before implementation, what must be reported after the fact, and what a PI should do when sponsor instructions conflict with IRB requirements.

Event or Action PI's IRB Obligation Timing
Protocol amendment Submit for review and approval before implementing (except emergency changes) Prior to implementation
Serious adverse event (unexpected) Report to IRB per protocol and local requirements Promptly, per defined timelines
Unanticipated problem involving risk Report to IRB and sponsor Per IRB-defined timeline
Deviation from approved protocol Report to IRB; distinguish between minor deviation and major deviation Per IRB requirements (major deviations promptly)
Continuing review Submit renewal before approval expires; no research activities during lapse Before expiration of approval
Study closure Submit final report and closeout to IRB Upon study completion or termination

Questions in this area often present timeline pressure - a sponsor needs a procedure done immediately, but IRB approval hasn't been received. The correct PI action is to withhold the procedure until approval is in hand, except in genuine medical emergencies where participant safety is at immediate risk (in which case the deviation must be reported promptly afterward).

Safety Reporting: AEs, SAEs, and SUSARs

Safety reporting is a domain where clinical experience helps, but exam questions frequently expose gaps in candidates' understanding of definitions and reporting chains. Know these precisely.

Safety Reporting Definitions

The exam distinguishes these terms at a definitional and applied level.

  • Adverse Event (AE): Any untoward medical occurrence in a participant, not necessarily causally related to the investigational product.
  • Adverse Drug Reaction (ADR): An AE for which there is reasonable causal relationship to the investigational product.
  • Serious Adverse Event (SAE): Any AE resulting in death, life-threatening situation, hospitalization (or prolongation), persistent or significant disability, congenital anomaly, or a medically important event requiring intervention to prevent one of the above.
  • Unexpected Adverse Drug Reaction (UADR): An ADR whose nature, severity, or frequency is not consistent with the reference safety information (e.g., Investigator's Brochure).
  • SUSAR (Suspected Unexpected Serious Adverse Reaction): A serious, unexpected ADR with a reasonable causal relationship suspected. Fatal or life-threatening SUSARs must be reported to regulatory authorities within 7 calendar days; others within 15 calendar days.

The PI's direct obligation is to report SAEs to the sponsor immediately (or within 24 hours) and to report to the IRB per applicable timelines. The sponsor then manages regulatory reporting. Know whose job each step is - the exam distinguishes PI obligations from sponsor obligations carefully.

Common Exam Trap: Candidates often confuse "unexpected" with "severe." An adverse event can be severe (Grade 3 or 4 in severity) but still expected if it is listed in the Investigator's Brochure as a known reaction. Unexpectedness is defined by the reference safety document, not by clinical judgment about how bad the event is. The exam exploits this distinction regularly.

Protecting Vulnerable Populations

ICH E6(R3) and the Declaration of Helsinki both emphasize heightened protections for individuals who may be unable to freely consent or who are at elevated risk of coercion or undue influence. The ACRP-PI exam tests the PI's responsibility to identify vulnerability and respond appropriately.

Vulnerable populations include: minors, pregnant women (and their fetuses), prisoners, individuals with cognitive impairment or mental illness, economically disadvantaged persons, subordinates of investigators (students, employees), and patients in dependent relationships with the investigator. Each group introduces specific consent and oversight considerations that the PI must recognize before enrollment, not after.

A key principle: inclusion of vulnerable populations must be scientifically justified. Research involving additional risk should not enroll vulnerable participants unless the research cannot be conducted in a non-vulnerable population and the anticipated benefits justify the risks. The PI is responsible for making this assessment at the site level.

What ICH E6(R3) Changes for Ethical Oversight

If you have been studying from older materials or textbooks referencing E6(R2), this section is critical. ICH E6(R3) becomes the operative GCP standard for the exam on July 15, 2026. The Association of Clinical Research Professionals has aligned its content outline to the updated guideline, and questions will reflect the new framework.

Key changes relevant to Domain 2 include:

  • Risk-proportionate approach: E6(R3) explicitly introduces the principle that oversight and monitoring intensity should be proportionate to risk - lower risk studies may require less intensive controls. The PI must understand how to assess and document risk level.
  • Participant-centric language: The updated guideline shifts language toward participant protection as a primary driver, not just regulatory compliance. Expect questions that probe whether the PI's action genuinely protects the participant or merely satisfies a checkbox.
  • Quality by design: E6(R3) emphasizes building quality into study processes rather than detecting errors after the fact. For Domain 2, this means the PI is expected to proactively identify ethical risks in protocol design, not just respond to problems during conduct.
  • Decentralized trial considerations: E6(R3) addresses remote consent and electronic consent more directly than its predecessor, which is increasingly relevant as decentralized clinical trials become more common.

For a broader look at how regulatory updates affect exam preparation across all domains, see our detailed coverage in ACRP-PI Domain 3: Product Development and Regulation (12%) - Complete Study Guide 2026.

How Domain 2 Questions Are Written

The ACRP-PI exam uses 125 multiple-choice questions delivered over 180 minutes at PSI test centers or via live remote proctoring. An on-screen calculator and abbreviation resource are available. Questions include both scored items and unscored pretest items - you won't know which is which, so treat every question equally.

Domain 2 questions almost never ask for pure recall. Instead, they present a scenario with a PI, a participant, a protocol event, or an IRB interaction, then ask what the PI should do. The answer choices are typically all defensible actions - the question is which action is most appropriate given the circumstances.

Common question archetypes in Domain 2:

  1. The sponsor pressure scenario: A sponsor representative suggests a shortcut that would compromise consent or safety reporting. What should the PI do?
  2. The IRB timing question: A protocol change has been submitted to the IRB but approval hasn't arrived. Can the study proceed? What must happen first?
  3. The consent validity challenge: A participant signed consent but the process had a procedural flaw. What is the PI's next step?
  4. The AE classification question: Describe an event and ask whether it is serious, unexpected, or a SUSAR - and what reporting follows.
  5. The vulnerable population scenario: A prospective participant has reduced capacity or is in a coercive environment. What protections apply?

Understanding the question style is half the battle. For a full breakdown of exam format and difficulty calibration, see How Hard Is the ACRP-PI Exam? Complete Difficulty Guide 2026.

Domain 2 Study Schedule

Because Domain 2 is the highest-weighted area, it warrants dedicated early study time before you move into operational domains. Here is a practical sequence for candidates with 6-8 weeks before the exam.

Week 1

Ethical Foundations

  • Read Belmont Report in full - annotate each principle with a real-world PI scenario
  • Review Declaration of Helsinki articles most relevant to PI responsibility
  • Summarize Nuremberg Code in your own words (the Feynman technique works well here)
Week 2

Informed Consent and IRB Obligations

  • Map all required consent elements from ICH E6(R3) Chapter on participants
  • Create a decision tree for when re-consent is required
  • Review IRB reporting timelines by event type using the comparison table in this guide
Week 3

Safety Reporting and Vulnerable Populations

  • Drill AE/SAE/SUSAR definitions until classification is automatic
  • Practice identifying SUSAR reporting windows (7-day vs. 15-day)
  • Review vulnerable population protections by group (minors, prisoners, cognitively impaired)
Week 4

ICH E6(R3) Integration and Practice Questions

  • Focus on E6(R3) changes: risk-proportionality, participant-centric language, quality by design
  • Complete 40-50 Domain 2 practice questions with timed conditions
  • Review every wrong answer at the principle level, not just the fact level

After completing Domain 2, move to ACRP-PI Domain 4: Clinical Trial Operations (21%) - Complete Study Guide 2026 - the second-heaviest domain - while your ethical reasoning frameworks are still sharp. Overlapping ethical obligations appear throughout Domain 4 content, and studying them in sequence reinforces retention.

For timed practice under realistic exam conditions, use the ACRP-PI practice test platform which structures questions by domain so you can target Domain 2 specifically before moving to full-length mixed sets.

Key Takeaway

Domain 2 rewards preparation depth over breadth. Three documents - Belmont, Helsinki, and ICH E6(R3) - underpin most questions. Master their principles at the application level, not just their names, and you will answer scenario questions from a principled foundation rather than guessing from experience.

Candidates who want to see how Domain 2 performance affects overall exam outcomes relative to your peers should review ACRP-PI Pass Rate 2026: What the Data Shows for context on score distribution and what a passing performance typically looks like across the exam as a whole.

For the complete preparation framework that integrates Domain 2 with all other content areas, the ACRP-PI Study Guide 2026: How to Pass on Your First Attempt provides a structured plan from registration through exam day. It includes guidance on navigating the fee structure - ACRP members pay $435 at early-bird pricing versus $485 for non-members - and the eligibility requirements including the 3,000-hour threshold and doctoral/licensed provider prerequisites.

Frequently Asked Questions

How many questions on the ACRP-PI exam come from Domain 2?

The exam contains 125 total questions, including scored items and unscored pretest items. At 22% weighting, Domain 2 represents approximately 27 of the scored questions. However, because pretest items are not identified, you should treat every question as scored regardless of domain.

Does the exam use ICH E6(R2) or E6(R3)?

ICH E6(R3) replaces E6(R2) as the operative GCP guideline beginning July 15, 2026. If you are sitting the exam at or after that date, study E6(R3). The ACRP-PI exam is an ICH-only exam, meaning it draws exclusively on internationally recognized standards rather than any single country's regulations.

What is the most important sub-topic within Domain 2 to prioritize?

Informed consent is the highest-frequency sub-topic in this domain - including required elements, process requirements, re-consent triggers, and consent in special populations. Safety reporting (AE/SAE/SUSAR classification and reporting timelines) is a close second. Together, these two areas cover the majority of Domain 2 question scenarios.

Is clinical experience enough to pass Domain 2 without additional study?

Clinical experience is valuable context but is not sufficient on its own. The exam tests foundational documents (Belmont Report, Declaration of Helsinki, ICH E6(R3)) at a level of precision that most practitioners haven't revisited since training. Candidates who rely solely on site experience often miss questions that require knowing the exact principle or reporting timeline from those documents.

Where can I find Domain 2 practice questions specifically?

The ACRP-PI practice test platform includes questions organized by domain, allowing you to target Domain 2 scenarios before progressing to full mixed-exam simulations. For guidance on question format and what to expect, see Best ACRP-PI Practice Questions 2026: What to Expect on the Exam.

Ready to Start Practicing?

Test your Domain 2 knowledge with scenario-based questions built to match the ACRP-PI exam format. Target ethical frameworks, informed consent, and safety reporting in focused domain-specific sets - then advance to full-length timed exams when you're ready.

Start Free Practice Test

Ready to pass your ACRP-PI exam?

Put this into practice with free ACRP-PI questions across every exam domain.